News
Filter
-
LifeArc bolsters scientific leadership by appointing new Chief Scientific Officer
-
Meet the 2021–2022 LifeArc Knowledge Transfer Innovation Fellows
-
Reflecting on 2021 – a year of progress
-
LifeArc participates in Series A funding round for company developing pioneering new gene therapies for neurodegenerative diseases
-
LifeArc unveils new strategy and £1.3 billion spend to drive life-changing science
-
New approach provides potential vaccine and treatment for Alzheimer’s
-
Advanced diagnosis for patients with rare conditions
-
10 new data-driven health companies selected for KQ Labs accelerator programme
-
LifeArc’s technology transfer team supports MRC researchers in making cryo-electron microscopy even sharper
-
LifeArc invests in company developing personalised drug and digital combination treatments
-
Accelerating the search for new treatments for neurodegenerative diseases
-
KQ Labs data driven health accelerator announces its first exit, as Glamorous AI is acquired by X-Chem Inc
